Progressed the dose expansion phase of the Phase 1/2 pheNIX trial evaluating HMI-102 gene therapy for the treatment of adults with phenylketonuria ...
https://www.google.com/url?rct=j&sa=t&url=https://www.globenewswire.com/news-release/2021/05/06/2224994/0/en/Homology-Medicines-Reports-First-Quarter-2021-Financial-Results-and-Recent-Highlights.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNEAt7pLEyMHcv5HIa_Y4IS5l78VZQ
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.